Last reviewed · How we verify
NCT03386136: TOGA
Therapeutic Oxygen for Gastrointestinal Atony (TOGA)
Phase 1 trial testing 100% Oxygen in Ileus in 17 participants. Completed in 17 October 2019.
17 October 2019
Quick facts
| Lead sponsor | University of Florida |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 17 |
| Start date | 25 January 2018 |
| Primary completion | 17 October 2019 |
| Estimated completion | 17 October 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 100% Oxygen — full drug profile →
Conditions studied
- Ileus — all drugs for Ileus →
- Ogilvie Syndrome — all drugs for Ogilvie Syndrome →
- Small Bowel Obstruction — all drugs for Small Bowel Obstruction →
Sponsor
University of Florida
Who can join
Adults 18 to 100, any sex, with Ileus or Ogilvie Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a non invasive study to see if 100% oxygen therapy will help to resolve an intestinal obstruction.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
TOGA Therapeutic Oxygen for Gastrointestinal Atony.
Weiner B, Forsmark C, Khular V, Bauman A, et al · · 2024 · cited 2× · PMID 39131150 · DOI 10.1016/j.gastha.2023.12.013
Verify or expand the search:
- PubMed search for NCT03386136
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of 100% Oxygen
Trials testing the same drug.
- NCT06740305 — NASA Prebreathe Study · Phase 1 · suspended
- NCT04043299 — Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes · Phase 3 · unknown
- NCT03239678 — Safe Time for Apnea After Preoxygenation · NA · completed
Other recruiting trials for Ileus
Currently open trials in the same condition.
- NCT07432542 — Pelvic Floor Peritoneal Closure to Prevent Postoperative Ileus in Mid-Low Rectal Cancer Surgery · NA · active not recruiting
- NCT06815822 — Prevention of Postoperative Hernias in Emergency Surgery · recruiting
Other University of Florida trials
Trials by the same sponsor.
- NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
- NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
- NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
- NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
- NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03386136 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Florida
- Last refreshed: 12 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03386136.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing